About
Technology
Issues
FAQ
Links
Official Page
HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.